Pharma and Biotech
| Competitors: | Hemogenyx Pharmaceuticals |
| Executive Director: | Daniel Gooding |
| Independent Non-Executive Director: | Madeleine Kennedy |
| Non-Executive Chairman: | Julian Gilbert |
| Non-Executive Dir: |
| Address: | C/O Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ |
| Phone: | +44 (0)1223 627222 |
| Website: | https://nuformix.com/ |
| Sector: | Pharma and Biotech(LSE) |
| ISIN: | GB00BYW79Y38 |
| Currency | UK Pounds |
| Share Price | 0.34p |
| Change Today | 0.005p |
| % Change | -1.47 % |
| 52 Week High | 0.49 |
| 52 Week Low | 0.047 |
| Volume | 24,334,467 |
| Shares Issued | 2,109.75m |
| Market Cap | £7.07m |
| RiskGrade | 322 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:49 | 138,784 @ 0.32p |
| 15:41 | 277 @ 0.36p |
| 15:40 | 400,701 @ 0.32p |
| 15:36 | 277 @ 0.36p |
| 15:34 | 277 @ 0.36p |
You are here: research